Cancer Res Treat.  2016 Jul;48(3):883-891. 10.4143/crt.2015.218.

Responses to Overdiagnosis in Thyroid Cancer Screening among Korean Women

Affiliations
  • 1Graduate School of Cancer Science and Policy, Goyang, Korea. kschoi@ncc.re.kr
  • 2National Cancer Control Institute, National Cancer Center, Goyang, Korea.

Abstract

PURPOSE
Communicating the harms and benefits of thyroid screening is necessary to help individuals decide on whether or not to undergo thyroid cancer screening. This study was conducted to assess changes in thyroid cancer screening intention in response to receiving information about overdiagnosis and to determine factors with the greatest influence thereon.
MATERIALS AND METHODS
Data were acquired from subjects included in the 2013 Korean National Cancer Screening Survey (KNCSS), a nationwide, population-based, cross-sectional survey. Of the 4,100 respondents in the 2013 KNCSS, women were randomly subsampled and an additional face-to-face interview was conducted. Finally, a total of 586 female subjects were included in this study. Intention to undergo thyroid cancer screening was assessed before and after receiving information on overdiagnosis.
RESULTS
Prior awareness of overdiagnosis in thyroid cancer screening was 27.8%. The majority of subjects intended to undergo thyroid cancer screening before and after receiving information on overdiagnosis (87% and 74%, respectively). Only a small number of subjects changed their intention to undergo thyroid cancer screening from positive to negative after receiving information on overdiagnosis. Women of higher education level and Medical Aid Program recipients reported being significantly more likely to change their intention to undergo thyroid cancer screening afterreceiving information on overdiagnosis,whilewomen with stronger beliefs on the efficacy of cancer screening were less likely to change their intention.
CONCLUSION
Women in Korea appeared to be less concerned about overdiagnosis when deciding whether or not to undergo thyroid cancer screening.

Keyword

Medical overuse; Thyroid neoplasms; Early detection of cancer; Intention

MeSH Terms

Cross-Sectional Studies
Early Detection of Cancer
Education
Female
Humans
Intention
Korea
Mass Screening*
Medical Overuse*
Surveys and Questionnaires
Thyroid Gland*
Thyroid Neoplasms*

Figure

  • Fig. 1. Positive intention to undergo thyroid cancer screening before and after receiving information on overdiagnosis, stratified by age.


Cited by  2 articles

Proteomic Biomarkers for Bisphenol A–Early Exposure and Women’s Thyroid Cancer
Ho-Sun Lee, Yunkyeong Kang, Kyung Tae, Gyu-Un Bae, Jong Y. Park, Yoon Hee Cho, Mihi Yang
Cancer Res Treat. 2018;50(1):111-117.    doi: 10.4143/crt.2017.001.

Recent Changes in the Incidence of Thyroid Cancer in Korea between 2005 and 2018: Analysis of Korean National Data
Yun Mi Choi, Jiwoo Lee, Mi Kyung Kwak, Min Ji Jeon, Tae Yong Kim, Eun-Gyoung Hong, Won Bae Kim, Won Gu Kim
Endocrinol Metab. 2022;37(5):791-799.    doi: 10.3803/EnM.2022.1533.


Reference

References

1. Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat. 2015; 47:127–41.
Article
2. Cho BY, Choi HS, Park YJ, Lim JA, Ahn HY, Lee EK, et al. Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades. Thyroid. 2013; 23:797–804.
Article
3. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010; 102:605–13.
Article
4. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic": screening and overdiagnosis. N Engl J Med. 2014; 371:1765–7.
5. Lee JH, Shin SW. Overdiagnosis and screening for thyroid cancer in Korea. Lancet. 2014; 384:1848.
Article
6. Waller J, Whitaker KL, Winstanley K, Power E, Wardle J. A survey study of women's responses to information about overdiagnosis in breast cancer screening in Britain. Br J Cancer. 2014; 111:1831–5.
Article
7. Gummersbach E, Piccoliori G, Zerbe CO, Altiner A, Othman C, Rose C, et al. Are women getting relevant information about mammography screening for an informed consent: a critical appraisal of information brochures used for screening invitation in Germany, Italy, Spain and France. Eur J Public Health. 2010; 20:409–14.
Article
8. Saalasti-Koskinen U, Makela M, Saarenmaa I, Autti-Ramo I. Personal invitations for population-based breast cancer screening. Acad Radiol. 2009; 16:546–50.
Article
9. Zapka JG, Geller BM, Bulliard JL, Fracheboud J, Sancho-Garnier H, Ballard-Barbash R. Print information to inform decisions about mammography screening participation in 16 countries with population-based programs. Patient Educ Couns. 2006; 63:126–37.
Article
10. Bekker HL. Decision aids and uptake of screening. BMJ. 2010; 341:c5407.
Article
11. Duffy SW, Tabar L, Chen TH, Yen AM, Dean PB, Smith RA. What information should be given to women invited for mammographic screening for breast cancer? Womens Health (Lond Engl). 2006; 2:829–33.
Article
12. Jorgensen KJ, Gotzsche PC. Content of invitations for publicly funded screening mammography. BMJ. 2006; 332:538–41.
Article
13. Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, et al. Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ. 2013; 346:f158.
Article
14. Waller J, Douglas E, Whitaker KL, Wardle J. Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. BMJ Open. 2013; 3:e002703.
15. Mathieu E, Barratt AL, McGeechan K, Davey HM, Howard K, Houssami N. Helping women make choices about mammography screening: an online randomized trial of a decision aid for 40-year-old women. Patient Educ Couns. 2010; 81:63–72.
Article
16. Schonberg MA, Hamel MB, Davis RB, Griggs MC, Wee CC, Fagerlin A, et al. Development and evaluation of a decision aid on mammography screening for women 75 years and older. JAMA Intern Med. 2014; 174:417–24.
Article
17. Esserman LJ, Thompson IM Jr, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013; 310:797–8.
18. Trevena LJ, Zikmund-Fisher BJ, Edwards A, Gaissmaier W, Galesic M, Han PK, et al. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak. 2013; 13 Suppl 2:S7.
Article
19. Hersch J, Barratt A, Jansen J, Houssami N, Irwig L, Jacklyn G, et al. The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial. BMJ Open. 2014; 4:e004990.
Article
20. Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH. Informed decision making: what is its role in cancer screening? Cancer. 2004; 101(5 Suppl):1214–28.
Article
21. Reyna VF, Nelson WL, Han PK, Pignone MP. Decision making and cancer. Am Psychol. 2015; 70:105–18.
Article
22. Han MA, Choi KS, Lee HY, Kim Y, Jun JK, Park EC. Current status of thyroid cancer screening in Korea: results from a nationwide interview survey. Asian Pac J Cancer Prev. 2011; 12:1657–63.
23. Trevena LJ, Davey HM, Barratt A, Butow P, Caldwell P. A systematic review on communicating with patients about evidence. J Eval Clin Pract. 2006; 12:13–23.
Article
Full Text Links
  • CRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr